Arrow-right Camera
The Spokesman-Review Newspaper

The Spokesman-Review Newspaper The Spokesman-Review

Spokane, Washington  Est. May 19, 1883
Cloudy 52° Cloudy

Tag search results

Tags let us describe our content with keywords, making it easier to find what you're most interested in. Use the search box to look for tags, or explore our coverage with the lists below.


Mind-altering, ketamine-like drug OK’d for severe depression

A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness.

Experimental app might spot drug overdoses in time to help

Too often people die of an opioid overdose because no one’s around to notice they’re in trouble. Now scientists are creating a smartphone app that beams sound waves to measure breathing – and summon help if it stops.

Eli Lilly to spend about $8B on Loxo Oncology

Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker seeks to bulk up on cancer treatments that target certain gene abnormalities. Loxo Oncology’s product portfolio includes a drug that could launch next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid cancers.

Where they stand: Cathy McMorris Rodgers, Lisa Brown give stances on marijuana, opioid addiction treatment and drugs

Rep. Cathy McMorris Rodgers has softened her stance somewhat on the legalization of marijuana, six years after Washington state voters approved the creation of a recreational market for the drug. Lisa Brown said she supports efforts in the House to address the growing number of opioid overdose deaths in the United States, but prefers a different proposal that includes a dedicated commitment of funds.